[ Price : $8.95]
Federal Register notice: FDA announces a 12/17 joint advisory committee meeting to discuss strategies to increase the availability...[ Price : $8.95]
A new study concludes that the FDA Amendments Act (FDAAA) of 2007 has led to more clinical trials being registered and results bei...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Imclones Lartruvo.[ Price : $8.95]
FDA publishes a draft guidance to assist sponsors who develop drug products that may result in testicular toxicity.[ Price : $8.95]
FDA deputy commissioner Anna Abram tells the JAX Healthcare Forum how innovation is part of FDAs DNA.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Genentechs Tecentri...[ Price : $8.95]
Federal Register notice: FDA submits to OMB an information collection extension for its guidance on Formal Meetings With Sponsors ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Wyeths Besponsa (in...